Efficacy News and Research

RSS
Bayhill's BHT-3034 receives FDA IND clearance for treatment of myasthenia gravis

Bayhill's BHT-3034 receives FDA IND clearance for treatment of myasthenia gravis

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

VaxInnate receives $196 million BARDA contract to develop novel flu vaccines

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease

New drug approved for COPD by the FDA

New drug approved for COPD by the FDA

QLT fourth quarter revenues decrease 7.3% to $10.0 million

QLT fourth quarter revenues decrease 7.3% to $10.0 million

FDA approves Forest Labs' Daliresp to treat COPD

FDA approves Forest Labs' Daliresp to treat COPD

Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy

Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy

Intercell reports EUR 255.2m net loss for full year 2010

Intercell reports EUR 255.2m net loss for full year 2010

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Cummings School granted U.S. Patent for antibody-based treatment against Hemolytic Uremic Syndrome

Leptin receptor antagonist peptide demonstrates efficacy against triple negative breast cancer

Leptin receptor antagonist peptide demonstrates efficacy against triple negative breast cancer

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development

Cancer drug may help combat flu

Cancer drug may help combat flu

HHS awards two contracts to accelerate flu vaccine availability

HHS awards two contracts to accelerate flu vaccine availability

CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine

CellSeed, LA BioMed enter two-year research agreement to study core technology in regenerative medicine

Treat discomfort not fever say the new pediatric guidelines

Treat discomfort not fever say the new pediatric guidelines

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

AFFiRiS AG - Alzheimer's vaccines generate further cash flow

TCD announces first patient treated in its TCD-717 Phase I trial

TCD announces first patient treated in its TCD-717 Phase I trial

ACT Biotech files SPA with FDA for telatinib combination Phase 3 trial for stomach cancer

ACT Biotech files SPA with FDA for telatinib combination Phase 3 trial for stomach cancer

Tenofovir gel may help reduce risk of HIV from anal sex

Tenofovir gel may help reduce risk of HIV from anal sex

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.